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Repeated stimulation of CD4 effector T cells 
can limit their protective function
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Chronic infections often result in CD8 T-cell deletion or functional nonresponsiveness. 
However, to date no definitive studies have attempted to determine the impact of repeated 
T cell receptor stimulation on CD4 effector T cell generation. We have determined that 
when antigen presentation is limited to 2 d, optimum in vitro CD4 effector generation is 
achieved. Alternatively, repeated stimulation results in decreased CD4 effector expansion, 
decreased cytokine production, and altered migration. Similarly, functionally impaired 
effectors develop in vivo when antigen-pulsed antigen-presenting cells are replenished every 
24 h during a primary immune response. CD4 effectors that are generated with repeated 
stimulation provide no protection during influenza infection, and have an impaired ability to 
provide cognate help to B cells. These results suggest that duration of antigen presentation 
dictates CD4 effector function, and repeated T cell receptor stimulation in vitro and in vivo 
that exceeds an optimal threshold results in effectors with impaired function.
 
Efficient priming of naive T cells is essential
for the generation of effective immunity to
pathogens. The initiation of a protective adap-
tive immune response depends on successful
interactions between T cells and APCs. When
naive CD4 T cells successfully recognize anti-
gen (Ag) that is presented by APCs, they ex-
pand into highly activated effectors that exhibit
immediate cytokine-secreting function (1–3). We
hypothesize that reaching an optimal threshold
of TCR stimulation in the initial phases of a T
cell response determines if an effector survives
and acquires the functions that are necessary to
provide cytokine or cognate help to other
lymphocytes.
The progressive differentiation model that
was proposed by Lanzavecchia and colleagues
(4, 5) suggests that the level of TCR signal that
is accumulated determines if T cells reach hier-
archical thresholds for induction of prolifera-
tion and differentiation. In this model, random
encounters of variable duration with APCs and
cytokines result in the generation of effectors
with different fates (6). The concept that TCR
signal accumulation results in progressive differ-
entiation of effectors is supported by the finding
that the commitment of naive T cells to prolif-
erate is reached in 6–12 h if they are stimulated
by a high dose of Ag plus costimulation (7),
but 40 h is required to generate an expanded
effector population (8). Moreover, it has been
demonstrated that multiple rounds of prolifer-
ation, and 2–4 d of culture, are required for
naive T cells to expand into effectors that are
capable of rapidly producing large amounts of
cytokines (9, 10).
Less is known about the impact of repeated
TCR stimulation on effector development, or
the ability of the effectors that are generated to
protect against infectious agents and provide
help to other lymphocytes (11). The current
body of literature primarily has focused on
determining the minimal stimulation that is
necessary to drive multiple rounds of T cell
division (7, 12–14), rather than the optimal
stimulation that is required for the generation
of functional effectors.
The generation of effectors in vitro typi-
cally involves stimulating naive CD4 T cells
with Ag-pulsed APCs, often with exogenous
IL-2 and polarizing cytokines. Our previous
studies demonstrated that under these condi-
tions, the Ag-pulsed APCs disappear from cul-
ture within 48–60 h of culture initiation, and
that cell division in the final 2–4 d of a 4-d
culture is driven by cytokine (IL-2) stimula-
tion. We define this set of conditions, where
Ag-pulsed APCs are added only at the initia-
tion of culture, as acute Ag stimulation. Alter-
natively, prolonging Ag stimulation beyond
the first 2 d of culture resulted in reduced
numbers of effectors (8). Therefore, we define
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repeated TCR stimulation (RS) as that which results from
the addition of Ag-pulsed APCs on the day of culture initia-
tion and every 24 h for the duration of the 4 d culture. Here,
we further investigate the consequences of acute versus re-
peated exposure to Ag-pulsed APCs on the generation and
function of CD4 effector and memory T cells.
The results of this study reveal that highly activated, and
well-polarized effectors can be generated under conditions
of RS. However, RS leads to the generation of effectors that
produce lower levels of cytokines in response to restimula-
tion than acutely stimulated effectors. Moreover, repeatedly
stimulated Th1 effectors fail to provide protection in mice
that were lethally challenged with influenza virus. Addition-
ally, Th2 polarized effectors that were generated with RS fail
to provide cognate help to B cells. We also have investigated
the effects of acute and RS in vivo, and have determined
that RS profoundly affects the migration and function of the
resulting effectors. We suggest that an initial 48–60 h of
TCR stimulation during T cell priming results in an ex-
panded population of optimally functional effectors that traf-
fic efficiently through lymphoid organs, and are able to par-
ticipate in antiviral responses and provide B cell help. We
also suggest that longer durations of Ag stimulation result in
T cells that exhibit dramatically reduced effector function,
and fail to provide other lymphocytes with the cognate help
that is necessary to stimulate vigorous immune responses.
 
RESULTS
Repeated T cell receptor stimulation results in poor 
effector expansion
 
Naive and TCR transgenic (Tg) CD4 T cells were cultured
with acute or repeated stimulation to generate Th1 and Th2
polarized effectors. By day 4, cell recovery in Th1 and Th2
cultures that were exposed to RS was 50% reduced, com-
pared with acute stimulation (Fig. 1, A and B, respectively).
Interestingly, carboxyfluorescein succinimidyl ester (CFSE)
profile analysis showed that acutely and repeatedly stimulated
effectors underwent equivalent rounds of division through-
out the culture (Fig. 1 C). Analysis of cell viability indicated
that the repeatedly stimulated effectors had fewer viable cells;
this suggested that the decrease in effector recovery could be
attributed to increased cell death compared with effectors
that were generated with acute stimulation (Fig. 1 D).
 
Repeated stimulation impairs effector cytokine production
 
Because the protective immune functions of T cells are me-
diated, in large part, by the effector cytokines that they pro-
duce (15, 16), we examined the effects of acute versus RS on
the cytokine production by Th1 and Th2 effectors. Acutely
and repeatedly stimulated Th1 and Th2 effectors had the ca-
pacity to secrete polarized cytokines in response to plate-
bound anti-CD3 in a dose dependent manner (Fig. 2, A and
B, respectively). However, repeatedly stimulated effectors
produced significantly reduced amounts of IFN
 
 
 
 (Th1) and
IL-4 (Th2) when compared with effectors that were gener-
ated with acute stimulation (Fig. 2, A and B). To determine
if the reduction in cytokine production by repeatedly stimu-
lated effectors was a result of fewer effectors that were capa-
ble of producing cytokines, or if the effectors were produc-
ing less cytokine on a per cell basis, intracellular cytokine
staining (ICCS) was performed on viable effectors that were
restimulated for 24 h with optimal concentrations of Ag-
pulsed APCs. Fig. 2, C and D show that fewer effectors that
were generated with RS were capable of producing cyto-
kines, and those that were producing cytokines were making
less cytokine on a per cell basis.
 
Impaired cytokine production persists in memory T cells
 
Several groups have reported that, following primary stimu-
lation, T cells can enter a state of transient unresponsiveness
(17, 18). This nonresponsive state is of limited duration, and
lasts only 6 d for CD4 T cells and 2 weeks for CD8 T cells
(17, 18). Additionally, the repeatedly stimulated effectors
were tested for cytokine production immediately following
their last encounter with Ag-pulsed APCs, whereas the
acutely stimulated effectors were tested for cytokine produc-
tion following 2 d of “rest” without Ag-pulsed APC stimu-
lation. Therefore, to determine if RS during CD4 effector
generation is inducing a temporary state of nonresponsive-
ness, we adoptively transferred 4 d Th1 and Th2 polarized
effectors, generated with acute or RS, into adult thy-
mectomized, lethally irradiated, bone marrow reconstituted
(AT
 
 
 
BM) host mice and waited for 3 wk for the progres-
sion to resting memory (9). Fig. 3 A indicates that when
equal numbers of viable 4-d Th1 and Th1RS effectors were
Figure 1. Repeated Ag stimulation impairs effector T cell expansion. 
Naive AND TCR Tg CD4 T cells, stimulated with acute or repeated Ag-pulsed 
APC stimulation under (A) Th1 or (B) Th2 polarizing conditions were enu-
merated, (C) analyzed for CFSE dye loss, and (D) cell viability. Data are means 
of triplicate cultures   SD. Data shown in (C) is one representative of triplicate 
cultures. Data are representative of three to six independent experiments. 
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transferred into AT
 
 
 
BM hosts there was no significant dif-
ference in the number of memory T cells that were recov-
ered (center graph, 25 d memory). However, when we ex-
trapolate from the total number of effectors that originally
were generated in the primary cultures (
 
 
 
36 
 
 
 
 10
 
6
 
 Th1 and
 
 
 
19 
 
 
 
 10
 
6
 
 Th1RS), the total number of Th1RS memory
cells that are generated as a result of RS would be reduced
compared with Th1 memory cells (right graph). Fig. 3 B in-
dicates that when equal numbers of viable 4-d Th2 and
Th2RS effectors were transferred into AT
 
 
 
BM hosts, there
was a 25% reduction in the ability of Th2RS effectors that
were generated with RS to progress to memory (center
graph). Even more striking was the 
 
 
 
75% reduction in the
number of Th2RS memory cells that were generated as a re-
sult of RS that would have resulted if the total number of ef-
fectors that were generated in primary culture (
 
 
 
55 
 
 
 
 10
 
6
 
Th2 and 
 
 
 
25 
 
 
 
 10
 
6
 
 Th2RS) had been transferred into the
AT
 
 
 
BM hosts (right graph). We then restimulated equal
numbers of memory cells with Ag-pulsed APCs for 24 h to
determine if the transition to a memory-like state could re-
store the cytokine-producing function of repeatedly stimu-
lated T cells. Fig. 3, C and D indicate that the Th1 and Th2
memory cells that were generated from repeatedly stimu-
lated effectors still produced lower levels of IFN
 
 
 
 and IL-4,
respectively, compared with memory cells that were gener-
ated from acutely stimulated effectors.
 
Repeated T cell receptor stimulation impairs polyclonal CD4 
T cell responses
 
The examination of TCR Tg CD4 T cells did not enable us
to observe the evolution of a normal polyclonal response,
and it was possible that the repeated Ag stimulation of poly-
clonal CD4 T cells could inhibit the functions of dominant
T cell clones while permitting the expansion of subdominant
clones. Therefore, it was important to demonstrate that the
effects of repeated Ag stimulation were not confined to the
responses of TCR Tg CD4 T cells. Naive polyclonal
BALB/c CD4 T cells were cultured under acute and RS
conditions with plate-bound anti-CD3 to generate Th1 and
Figure 2. Repeated Ag stimulation impairs effector cytokine pro-
duction. Viable AND TCR Tg (A) Th1 and (B) Th2 polarized 4 -d effectors 
were restimulated for 24 h with plate-bound anti-CD3 and supernatants 
were analyzed by ELISA. Four-d (C) Th1 and (D) Th2 effectors were cultured 
for 24 h without (open histograms) or with 10  g/ml of plate-bound anti-
CD3 restimulation (gray filled histograms) and analyzed by ICCS. Numbers 
within the histograms are % of cytokine-producing cells in the restimu-
lated cultures. Data in (A and B) are means of triplicate cultures   SD. 
Data in (C and D) are representative of triplicate cultures. Data shown are 
representative of three independent experiments.
Figure 3. Impaired cytokine production persists in memory T cells. 
AND TCR Tg CD4 T cells stimulated with acute or RS under (A) Th1 or (B) 
Th2 polarizing conditions were enumerated at days 0 and 4 of in vitro cul-
ture. 10   106 effectors were transferred into AT BM hosts and recov-
ered from lymph nodes and spleens 21 d later. Twenty-five–d memory T 
cells were enumerated, and extrapolated memory frequencies were deter-
mined by multiplying the number of memory cells recovered by the fraction 
of 4-d effectors that were generated in vitro. (C) Th1 and (D) Th2 polarized 
memory cells were restimulated for 24 h with Ag-pulsed APCs and super-
natants were analyzed by ELISA. Data (A and B) are means of triplicate cul-
tures   SD. Data (C and D) are representative of duplicate cultures. Data 
are representative of three independent experiments. 
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Th2 polarized effectors. Cell recovery in 4-d Th1 and Th2
cultures that were exposed to RS was reduced by at least
50%, compared with acute stimulation (Fig. 4, A and B, re-
spectively). We next examined the effects of acute versus RS
on the cytokine-producing potential of Th1 and Th2 effec-
tors. As observed with the TCR Tg CD4 effectors, repeat-
edly stimulated polyclonal effectors produced significantly
reduced amounts of IFN
 
 
 
 (Th1) and IL-4 (Th2) when com-
pared with effectors that were generated with acute stimula-
tion (Fig. 4, C and D), although they maintained their re-
spective polarized phenotypes.
 
Repeated Ag stimulation does not result 
in cytokine unresponsiveness
 
Strong TCR stimulation or Ag persistence can induce a state
of permanent unresponsiveness, or anergy (1, 19–21). This
hypo-responsive state often is defined as the maintenance of
T cells with a reduced ability to proliferate to IL-2 and/or
produce effector cytokines. To explore further the func-
tional potential of acutely versus repeatedly stimulated effec-
tors, we determined whether effectors that were generated
with RS were able to proliferate in response to IL-2 or
other cytokines that stimulate T cells through the common
 
 
 
-chain (19). Therefore, we CFSE-labeled 4-d Th1, Th1RS,
Th2, and Th2RS effectors and recultured them in fresh T
cell medium using optimal concentrations of common
 
 
 
-chain binding cytokines. The acutely and repeatedly stim-
ulated effectors divided in response to IL-2, IL-4, IL-7, and
IL-15 (Fig. 5 A). Interestingly, the repeatedly stimulated ef-
fectors expanded when recultured with IL-2 and IL-7,
whereas the acutely stimulated effectors simply were main-
tained during this reculture period (Fig. 5 B).
The 4-d primary effectors that were generated with RS
had the potential to have down-regulated TCR expression
as a result of excessive TCR stimulation during the primary
culture. Lower levels of TCR expression could have a dra-
matic impact on the ability to restimulate the effectors for
cytokine production. Despite the fact that 4-d Th2 effectors
that were stimulated repeatedly (Fig. 5 C-Th2RS) had a
slight down-regulation of their TCR (V
 
 
 
11 shown, V
 
 
 
3-
unpublished observation), these were the effectors that were
most capable of expanding in response to an excess of TCR
and IL-2 stimulation (Fig. 5 D).
 
Repeatedly stimulated effectors have unique 
phenotypic characteristics
 
CD69 is one of the most prominently cited markers of re-
cent Ag stimulation, and CD62L is one of the only mole-
cules that has been clearly established as playing an important
role in lymphoid homing and T cell trafficking in vivo;
therefore, we focused on the expression of these two mole-
cules on acutely and repeatedly stimulated effectors. Under
Th1 and Th2 polarizing conditions, RS resulted in a more
pronounced elevated level of expression of CD69 by 4-d ef-
fectors (Fig. 6, A and B). This indicated that RS is capable of
maintaining a high level of TCR signaling throughout the
4-d culture period. Additionally, repeatedly stimulated effec-
tors exhibited more extensive down-modulation of CD62L
under Th1 and Th2 polarizing conditions when compared
with effectors that were generated with acute stimulation.
This pattern of expression indicated that repeatedly stimu-
lated effectors underwent higher levels of activation and dif-
ferentiation compared with T cells that were generated with
acute stimulation.
Because expression of these markers has been shown to
be transient, a static view of 4 d-effectors did not allow us to
determine if there were differences in the kinetics of expres-
sion of these markers during effector generation. Therefore,
we labeled naive CD4 T cells with CSFE and analyzed the T
cells every 24 h during effector generation. These data are
presented as flow cytometry dot plot overlays of days 1 (red),
2 (blue), 3 (green), and 4 (orange). Th1 (Fig. 6 C) and Th2
(Fig. 6 D) effectors exhibited a progressive differentiation to a
CD62L
 
lo
 
 phenotype, which is more dramatic with RS. Tran-
sient expression of CD69 was observed when effectors were
generated with acute stimulation; up-regulated expression
lasted only for the first 48 h of culture, whereas CD69 ex-
pression was maintained throughout the entire 4 d of effector
generation when stimulated with RS (Fig. 6, C and D). We
also analyzed effectors that were stimulated acutely and re-
peatedly for expression of a variety of other activation mark-
ers (CD25, and CD44, unpublished data and references 3,
22); adhesion markers (CD43, CD49d, and CD162; refer-
ences 3, 22–24); and chemokine receptors CCR5 (unpub-
Figure 4. Repeated Ag stimulation impairs polyclonal CD4 T cell 
responses. Naive BALB/c polyclonal CD4 T cells that were cultured with 
acute or repeated plate-bound anti-CD3 stimulation under (A) Th1 or (B) 
Th2 polarizing conditions were enumerated. Four-d (C) Th1 and (D) Th2 
effectors were restimulated for 24 h with 10  g/ml plate-bound anti-CD3 
and supernatants were analyzed by ELISA. Data (A and B) are means of 
triplicate cultures   SD. Data (C and D) are one representative of triplicate 
cultures. Data are representative of two independent experiments. 
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lished data) and CXCR3 (25, 26). Overall, repeatedly stimu-
lated effectors exhibited extensive up-regulation of activation
markers, and an interesting blockade of the modulation of all
adhesion markers, except for CD62L (Fig. 6, E and F).
 
Repeated stimulation reduces the ability of Th1 effectors to 
protect mice from lethal influenza challenge
 
Previous studies showed that IFN
 
 
 
 production by Th1 and
Tc1 effectors is critical to clearance of influenza virus (3, 27–
29). Therefore, we tested the ability of adoptively transferred
acutely and repeatedly stimulated influenza-specific Th1 and
Th1RS effectors to protect mice that were challenged le-
thally with influenza virus. Fig. 7 A shows that all of the
mice that were infected with a 2LD
 
50
 
 of influenza virus sur-
vived when 5 
 
 
 
 10
 
6
 
 Th1 or Th1RS
 
 
 
effectors were trans-
ferred. When the number of effectors was reduced to 2.5 
 
 
 
10
 
6
 
 per mouse, Th1 effectors remained 100% protective
(Fig. 7 A-middle graph), but only 25% of the mice that re-
ceived Th1CS effectors were protected. Reducing the num-
ber of effectors to 0.5 
 
 
 
 10
 
6
 
 per mouse resulted in neither
the Th1 nor the Th1RS effector being able to protect
against a 2LD
 
50
 
 of influenza virus (Fig. 7 A-bottom graph).
The protection against lethal influenza challenge, afforded by
sufficient numbers of Th1 polarized effectors, correlated
with clearance of live virus from the lungs of the mice (un-
published data). These data indicate that it may be the quan-
tity of IFN
 
 
 
 which is produced by the CD4 effectors that
determines their ability to protect against lethal influenza
challenge. Interestingly, despite the unique phenotypic dif-
ferences between Th1 and Th1RS effectors (Fig. 6), the re-
peatedly stimulated effectors were recovered from the in-
fected mice in numbers similar to, or even slightly greater
than, the acutely stimulated effectors (Fig. 7 B). Further-
more, host CD4 and CD8 numbers were similarly recruited
to the lungs, draining lymph nodes, and spleens of infected
mice 4 d after receiving Th1 or Th1RS therapy (Fig. 6 D).
 
Repeated stimulation impairs the ability of Th2 effectors to 
provide cognate help
 
Following immunization, CD4 T cells provide helper func-
tions that are necessary for the generation of B cell–rich ger-
minal centers (30). To examine if repeatedly stimulated ef-
fectors could provide cognate help to B cells, we adoptively
transferred 4-d acutely and repeatedly stimulated Th2 effec-
Figure 5. Repeatedly stimulated effectors are responsive to re-
stimulation. Four-d AND TCR Tg effectors were CFSE labeled, recultured 
with common  -chain binding cytokines, and analyzed every 24 h for (A) 
CFSE dye loss (filled histograms   24 h, thick lines   48 h, thin lines   72 h), 
and (B) were enumerated. (C) TCR expression was determined by anti-
V 11 staining. (D) Effectors were restimulated with 10  g/ml plate-bound 
anti-CD3 and IL-2 and enumerated every 24 h of reculture. Histograms 
(A and C) are representative of triplicate cultures. Data (B and D) are 
means of triplicate cultures   SD. Data are representative of three 
independent experiments. 
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tors [OT-II TCR Tg, specific for a peptide of ovalbumin
(OVA)] into CD4 KO hosts (31). Analysis of host 4-hydroxy-
3-nitrophenyl acetate (NP)-binding B cells 16 d following
immunization revealed that almost three times as many NP-
specific B cells differentiated to a germinal center phenotype
(CD38
 
lo
 
PNA
 
hi
 
) in the presence of 10
 
7
 
 Th2 effectors that
were generated with acute stimulation, compared with Th2
effectors that were generated with RS (Fig. 8 A). Fig. 8 B
indicates that the transfer of 10
 
6
 
 or 10
 
7
 
 Th2 effectors gener-
ated a significant expansion of NP-specific, germinal center
phenotype B cells, whereas Th2RS were unable to generate
an expanded population of NP-specific, germinal center
phenotype B cells. Additionally, significantly more NP-spe-
cific IgG1 was detected in the serum of mice when 10
 
7
 
 Th2
effectors were transferred into NP-OVA immunized hosts,
compared with the transfer of 10
 
7
 
 Th2RS effectors (Fig. 8
C). We also assayed for the production of NP-specific IgM,
IgG2a, and IgG2b and found no significant production of
these antibodies (unpublished data).
 
Effectors generated with repeated stimulation in vivo have 
profound functional deficiencies
 
To reproduce conditions of RS in vivo we used an adoptive
transfer model that involves the cotransfer of Ag-pulsed DCs
with naive Ag-specific CD4 T cells into intact hosts. The
cotransfer of Ag-pulsed DCs with Ag-specific CD4 T cells
was necessary to optimize the primary stimulation of naive
CD4 T cells in vivo
 
,
 
 and enabled us to visualize the trans-
ferred T cells in sufficient numbers to perform phenotypic
and functional analysis. Previous studies suggested that Ag-
bearing APCs would be deleted rapidly by CTLs (13, 32–
34), and, in fact, Ag-pulsed DCs were undetectable within
2 d of transfer (R.A. Kemp, unpublished data). To over-
come this, we cotransferred Ag-pulsed DCs with naive T
cells at day 0, followed by transfer of Ag-pulsed DCs on days
1, 2, 3, and 4 of a 5-d in vivo immune response to model
RS. We modeled acute stimulation by cotransferring Ag-
pulsed DCs with naive T cells at day 0, followed by transfer
of nonpulsed DCs on days 1, 2, 3, and 4.
On day 5, following naive T cell transfer, we recovered
and analyzed donor T cells from peripheral lymph nodes,
spleens, lungs, and livers of host mice. Effectors that were
generated in vivo with acute stimulation migrated primarily
to the peripheral lymph nodes and spleens; few cells mi-
grated to tertiary sites (e.g., lungs, liver; Fig. 9 A). Con-
versely, we found increased migration of effectors that were
generated in vivo with RS to the spleen, lung, and liver (Fig.
9 A). This was not unexpected because phenotypic analysis
of the in vitro generated effectors revealed that repeatedly
stimulated effectors had a largely CD62L
 
lo
 
 phenotype, which
has been shown to promote T cell migration out of lymph
nodes (22). In fact, effectors that were generated in vivo
with acute stimulation had down-regulated CD62L to a
lower extent when compared with the highly activated phe-
notype of repeatedly stimulated Th1 effectors (Fig. 9 B).
This was true particularly for those effectors that had mi-
grated to the lymph nodes and spleen, because the effectors
that migrated to the lungs and liver exhibited a more highly
activated phenotype, regardless of the conditions under which
they were stimulated (Fig. 9 B).
Effectors that were generated in vivo with acute stimula-
tion resulted in an expanded population of Th1-like effec-
Figure 6. Repeated Ag stimulation generates effectors with a more 
activated phenotype. CD62L and CD69 surface expression on 4 d (A) Th1 
and (B) Th2 effectors (acute stimulation   filled histograms, RS   solid 
lines) were compared with naive (dotted line) AND TCR Tg CD4 T cells. 
(C) Th1 and (D) Th2 polarized T cells were analyzed every 24 h for surface 
CD62L or CD69 expression versus CFSE loss. (E) Th1 and (F) Th2 polarized T 
cells were analyzed every 24 h for surface CD43, CD162, CXCR3, or CD49d 
expression versus CFSE loss. Red   day 1, blue   day 2, green   day 3, 
and orange   day 4. Numbers represent percentage of day 4 T cells in 
the upper left quadrant. Data are representative of three to five indepen-
dent experiments. 
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tors with the capacity to produce high levels of IFN
 
 
 
 (Fig. 9,
C and D). In contrast, effectors that were generated in vivo
with RS failed to expand into a large population of IFN
 
 
 
–
producing effectors (Fig. 9 D). This is despite the fact that
RS in vivo resulted in only a modest increase in total num-
bers of effectors (Fig. 9 D). Repeatedly stimulated effectors
that were generated in vivo also produced less IL-2 when
compared with the acutely generated effectors; neither pop-
ulation produced any detectable IL-4 (unpublished data).
Because RS of T cells in vivo generated effectors of simi-
lar functional deficiencies as those that were generated in
vitro, we determined if the repeatedly stimulated effectors that
were generated in vivo could protect against lethal influenza
challenge. However, we needed to optimize the conditions of
in vivo stimulation of adoptively transferred HNT TCR Tg
CD4 T cells because it was demonstrated that large numbers if
IFN
 
 
 
–producing T cells would be necessary to protect mice
against lethal challenge. Careful titration of naive HNT TCR
Tg CD4 T cells and HNT-pulsed DCs enabled us to generate
enough acutely stimulated effectors to protect 80% of the
mice from lethal challenge (Fig. 9 E), whereas only 40% of
the mice survived when the T cells were stimulated with re-
peated injections of HNT-pulsed DCs.
 
DISCUSSION
 
Repeated stimulation of CD4 T cells during primary culture
led to the generation of effectors that produced strikingly
low levels of polarized cytokines, without changing their
overall polarization profiles. Repeated stimulation did not
induce anergy, as defined by the ability of effectors to prolif-
erate to 
 
 
 
-chain binding cytokines, restimulation with Ag,
or their ability to persist in vivo. The repeatedly stimulated
effectors also were inefficient in protection against influenza
virus and were inhibitory to cognate help.
We have determined that RS in vitro, whether achieved
by adding Ag-pulsed APCs every 24 h of culture or contin-
ual culture on plate-bound anti-CD3 (8) compromises pri-
mary CD4 T cell expansion and differentiation into cyto-
kine-producing effectors. This finding has significant
implications regarding the quality of the effectors that are
generated with the widely used 4–7 d plate-bound anti-
Figure 7. Repeatedly stimulated Th1 effectors fail to protect 
against lethal influenza infection. 5   106, 2.5   106, and 0.5   106 4-d 
HNT TCR Tg Th1 or Th1RS effectors were transferred into mice that were 
lethally infected with influenza virus. (A) Host survival was monitored, and 
(B) donor CD4 and host CD4 and CD8 T cells were enumerated 4 d follow-
ing transfer. Data (A) have a starting population of five mice per group. 
Data (B) are means of three mice per group   SD. Data are representative 
of two to three independent experiments.
Figure 8. Th2RS effectors provide minimal cognate B cell help in 
vivo. Four-d Th2 or Th2RS effectors, or PBS alone, were transferred into 
CD4 KO hosts that were immunized with NP-OVA in alum. Sixteen d follow-
ing immunization (A) NP  B cells were harvested from spleens and analyzed 
for germinal center (GC ) phenotype (CD38 /PNA ). (B) total numbers of 
NP GC  B cells were determined (*P   0.006, **P   0.007), and (C) serum 
was analyzed for NP-specific IgG1 (‡P   0.00006). Data (A) is one repre-
sentative of triplicate mice. Data (B and C) are means   SD of triplicate 
mice. Data are representative of three independent experiments. 
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CD3/anti-CD28 continual stimulation technique. Typically
this technique is used to stimulate polyclonal CD4 and CD8
T cells in vitro, which are then examined for effector re-
sponsiveness in a variety of model systems. A previous study
indicated that mitomycin-c–treated, Ag-pulsed APCs nor-
mally disappear from in vitro culture systems between 48–60 h
of culture with Ag-specific CD4 T cells, and that the late
phases of T cell differentiation are driven by growth-pro-
moting cytokines like IL-2 (8). We would suggest that plate-
bound anti-CD3 stimulation can only mimic Ag-pulsed
APC stimulation conditions if T cells are removed from the
plate-bound anti-CD3 stimulation between 48–60 h of cul-
ture and transferred, without washing, into uncoated tissue
culture containers for the remainder of the culture period.
Otherwise, repeatedly stimulated effectors will be generated,
which produce lower levels of cytokines upon restimulation,
are unable to provide protection against lethal influenza in-
fection, and are inhibitory to cognate help.
The acutely and repeatedly stimulated effectors that were
generated in vitro were able to secrete polarized cytokines in
a dose dependent manner in response to plate-bound anti-
CD3 restimulation, and were able to proliferate in response
to common 
 
 -chain cytokines and Ag restimulation; this
suggested that the repeatedly stimulated effectors were not
anergic. The ability of repeatedly stimulated effectors to pro-
liferate in response to cytokines like IL-7—known to be an
important CD4 T cell survival factor (35)—could help to
explain how repeatedly stimulated effectors persisted as
memory T cells following adoptive transfer, but died during
the in vitro cultures. The availability of common  -chain
cytokines in vivo could have provided survival or expansion
signals to repeatedly stimulated effectors. However, the re-
peatedly stimulated effectors remained poorly functional as
memory T cells, even though they were allowed to rest from
TCR stimulation for 21 d before being restimulated. The
implications of a persisting population of poorly functional
memory T cells has been discussed by many groups (36–39).
As individuals age, thymic output decreases and T cell reper-
toire diversity contracts; this makes it even more important
that any persisting memory T cells have optimal functional
capacities. The persistence of a large population of poorly
functional memory T cells could compromise severely the
ability to establish and maintain a diverse T cell repertoire of
functional effector and memory T cells.
The repeatedly stimulated effectors that were generated
in vitro inhibited the up-regulation of several surface mole-
cules that had been implicated in promoting T cell migration
to the spleen and tertiary sites; however, when the repeat-
edly stimulated effectors were generated in vivo, they did
migrate in greater numbers to the spleen and tertiary sites.
Figure 9. Repeated Ag stimulation in vivo leads to the generation 
of functionally impaired effectors. Naive AND TCR Tg   GFP CD4 T cells 
were mixed with PCCF-pulsed DCs and transferred into intact B10.Br mice. 
Subsequently, empty DCs (acute stimulation) or PCCF-pulsed DCs (RS) 
were injected every 24 h. On day 5, donor T cells (GFP CD4 ) were (A) 
enumerated, and assayed for expression of (B) CD69 versus CD62L, and 
(C) IFN  by ICCS with (filled histograms) or without (dotted lines) PMA/
ionomycin restimulation. (D) Total numbers of donor T cells recovered 
from all organs and total numbers of IFN   donor T cells were calculated. 
(E) On day 5 of in vivo HNT TCR Tg effector generation, host mice were 
lethally infected with influenza virus and survival was monitored. Donor 
cell frequencies in (A) and (D) are means   SD of triplicate mice. FACS 
analysis data (B and C) are one representative of triplicate mice. Data (E) 
have a starting population of five mice per group. Data are representative 
of two to four independent experiments.JEM VOL. 201, April 4, 2005 1109
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These findings seemed to be inconsistent, until we reconsid-
ered the modulation of CD62L to be not only a measure of
the level of activation of T cells, but also a potent modulator
of CD4 T cell migration between lymph nodes and tertiary
sites. Of the adhesion markers that we analyzed, CD62L is
the most thoroughly published as being able to dictate the
migration of T cells in and out of lymphoid compartments
(22), and it is with respect to CD62L expression that our in
vitro phenotype data and our in vivo migration data are most
consistent. Unfortunately, although the modulation of adhe-
sion molecules and chemokine receptors has been established
as being relevant for the trafficking and tissue localization of
activated T cells during immune responses (23), no study has
revealed conclusively the definitive combination of surface
molecule expression that is required to promote optimal
CD4 T cell migration between the lymph nodes, spleen, and
tertiary sites. The only conclusion that we have drawn from
this study is that repeated Ag stimulation in vivo led to the
generation of effectors that preferentially migrate to the
spleen and tertiary sites, rather than the lymph nodes, and
that repeated exposure to Ag stimulation has a dramatic im-
pact on the migratory potential of primary effectors. Further
studies are necessary to assess the role of individual surface
molecules—particularly those that failed to become up-reg-
ulated in response to RS—on the migration and interaction
of CD4 effectors with other lymphocytes in vivo.
The finding that large numbers of repeatedly stimulated
effectors failed to provide, or directly impaired, efficient
cognate help to B cells also had interesting implications, par-
ticularly with regards to immunization strategies. The poor
helper function was not surprising, considering that repeat-
edly stimulated Th2 effectors had a marked reduction in
their ability to produce IL-2 and IL-4. In fact, Grabstein et
al. (40) demonstrated that CD4 T cell–derived cytokines
were essential for contact-dependent T cell help for Ag-spe-
cific primary antibody responses. Specifically, the induction
of polyclonal Ig secretion required IL-4 and IL-5, and opti-
mal Ag-specific antibody formation required IL-2. Because
repeatedly stimulated Th2 polarized effectors produced low
levels of IL-2 and IL-4, it was not surprising that they failed
to provide optimum levels of cognate help to B cells. How-
ever, because the deficit in T cell help was most pronounced
when a high number of effectors were transferred, these re-
sults also would be consistent with the induction of an in-
hibitory mechanism at high T cell numbers. In fact, Eaton et
al. (31) recently reported that the transfer of too few or too
many naive CD4 T cells resulted in reduced cognate helper
function. Additionally, Erickson et al. (41) reported that al-
though CD40L ligation of CD40 on B cells has been used as
a potent immune adjuvant for short-lived humoral-mediated
immunity, increasing the magnitude of T cell help ablated
germinal center formation and prematurely terminated the
humoral immune response. In fact, the highly activated phe-
notype that was characteristic of repeatedly stimulated effec-
tors included a dramatic up-regulation of CD40L surface ex-
pression (unpublished data).
Several studies have focused on the impact of varied dura-
tions of Ag stimulation on CD4 T cell activation and devel-
opment of effector functions. However, the central question
of the studies that have published to date was to determine
the minimal duration of Ag stimulation that was necessary to
promote CD4 T cell activation, division, and development of
a cytokine-producing phenotype. The general consensus of
these studies was that longer durations of TCR stimulation—
from 8 to 20 h—were required to induce IL-2 and IFN 
production when Ag dose or affinity was low, and that high
Ag dose or affinity could drive more progressive differentia-
tion of proliferating T cells with as little as 4–6 h of TCR
stimulation (12, 42, 43). These studies suggested that the
quantity of TCR stimulation augmented T cell activation, at
least in part, by reducing the time that is required for cyto-
kine secretion. However, in most of the protocols, TCR
stimulation and/or T cell culture was terminated by 48 h, and
hence, did not determine the consequences of prolonged Ag
stimulation on the peak of effector responses, which typically
is determined at 4–7 d of a primary in vitro immune re-
sponse. Even studies that had attempted to establish if cell di-
vision could determine the development of cytokine produc-
tion by effectors used in vitro APC populations, which have
been established to be eliminated from in vitro cultures
within the first 48–60 h, and hence, would be unable to stim-
ulate repeated Ag stimulation (8, 10, 44). This study is the
first to determine the direct impact of repeated Ag presenta-
tion on primary CD4 effector responses.
Generally, it had been accepted that different pathogens
pose unique challenges to the immune system, and variations
in pathogen load and Ag persistence may affect primary T cell
responses dramatically. Recent studies revealed that Ag-bear-
ing DCs were highly efficient at recruiting and stably captur-
ing T cells with high avidity interactions for long periods of
time (6). The ability to introduce Ag-bearing DCs repeatedly
to induce effectors with lower IFN  production suggested
that persistent infections might induce poor CD4 T cell re-
sponses as a result of repeated Ag stimulation, particularly
when CTLs are not able to eliminate Ag-bearing APCs.
Studies of CD4 T cell responses to chronic or persistent
pathogens like HIV, Mycobacterium tuberculosis, EBV would
support the hypothesis that Ag persistence leads to T cell
death and functional nonresponsiveness of surviving CD4 T
cells. Following infection with HIV, M. tuberculosis, and
EBV, the frequency of Ag-specific CD4 T cells that is re-
covered from individuals during the latent phase of the in-
fection is significantly lower than that detected during pri-
mary infection, rather than maintaining high frequencies of
Ag-specific CD4 T cells throughout the infection (45–48).
Alternatively, failed attempts to vaccinate against diseases,
like leishmaniasis and malaria, suggested that the mainte-
nance of protective CD4 T cell–mediated immunity would
require the continued presence of Ag stimulation (49, 50).
These infections induce strong CD4 effector T cell re-
sponses, and because of their persistent nature, may drive all
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primed T cells to mount a secondary response. Recent at-
tempts at vaccination of mice with Leishmania major parasites
that only survived for a short time revealed that the T cells
that were generated with this vaccination strategy were par-
tially primed T cells and were protective to an extent. How-
ever, the most efficient protection against these pathogens
requires the maintenance of large numbers of highly acti-
vated Th1 effectors, and that resting memory T cells were
not present in sufficient numbers to afford a high level of
protection against rechallenge (49, 50). The findings regard-
ing chronic pathogen infections all have a common theme;
CD4 T cells that were generated in response to chronic
pathogen infections had qualitative deficits in their func-
tional capacities during the chronic phase of the infection.
Our study revealed that chronic Ag stimulation by Ag-bear-
ing APCs was too much of a good thing and may be the
critical factor that is involved in inducing a functionally non-
responsive state in Ag-specific T cells. These findings have
important implications for vaccine design and may lead to a
better understanding of how to combat persistent infections.
MATERIALS AND METHODS
Animals. AND (B10.Br) TCR Tg, AND TCR Tg   GFP, Thy1.1 HNT
(BALB/c ByJ) TCR Tg, OT-II (C57BL/6) TCR Tg, and BALB/c ByJ mice
were used as sources of naive CD4 T cells at 4–6 wk of age, and were bred in
the animal breeding facilities at Trudeau Institute. B10.Br, BALB/c ByJ, and
C57BL/6   CD4 KO mice were used at 2–4 mo of age, and were bred in the
animal facilities at Trudeau Institute or purchased from Jackson ImmunoRe-
search Laboratories. Experimental procedures were approved by Trudeau In-
stitute’s Institutional Animal Care and Use Committee.
Preparation of APCs. All cells were cultured in cell culture medium
(RPMI 1640 supplemented with penicillin [200  g/ml; Sigma-Aldrich],
streptomycin [200  g/ml; Sigma-Aldrich], glutamine [4 mM; Sigma-
Aldrich], 2-ME [50  M; Sigma-Aldrich], Hepes [10 mM; Sigma-Aldrich],
and 8% FBS [Intergen]). T-depleted B cells were prepared by isolating lym-
phocytes from spleens of intact mice in cell wash buffer [RPMI 1640 sup-
plemented with Hepes and 1% FBS], and depleting T cells using antibody
and complement as described previously (8). The T-depleted spleen cells
were stimulated for 2–3 d with LPS and dextran sulfate (Sigma-Aldrich) as
described previously (8). Bone marrow–derived DCs were prepared by iso-
lating cells from bone marrow of B10.Br or BALB/c ByJ mice, and cultur-
ing at 4   105 cells/ml with 20 ng/ml GM-CSF (Preprotech) and 20 ng/ml
IL-4 for 6–8 d, with 25 ng/ml LPS (Sigma-Aldrich) added for the last 18–
24 h. The DCs were loaded with 5  M pigeon cytochrome c peptide frag-
ment (PCCF) or HNT peptide. B cells were treated with 100  g/ml of mi-
tomycin-c (Sigma-Aldrich) before use, whereas DCs that were used in vivo
were not treated.
Naive CD4 T cell isolation. The enrichment of naive CD4 T cells from
pooled spleen and lymph node lymphocytes was performed as described
previously (8). In brief, lymphocytes were passed through nylon wool,
treated with MHC class II and CD8 depletion antibodies followed by com-
plement and DNase I (Sigma-Aldrich) treatment, and discontinuous Percoll
(Sigma-Aldrich) gradient separation. Cells at the 63%/80% Percoll interface
were used for T cell assays. The purified cell populations were  85% CD4 
cells, 90–95% of which had a naive phenotype (CD45RBhi, CD62Lhi,
CD44low, CD25low).
In vitro culture of CD4 T cells and memory generation. Naive
TCR Tg CD4 T cells (3   105/ml) were labeled with CFSE (Molecular
Probes Inc.) as previously described (8), and cultured with T-depleted
splenic APC blasts (3   105/ml) pulsed with 5  M peptide Ag (AND TCR
Tg T cells were stimulated with B10.Br APC   PCCF peptide; HNT
TCR Tg T cells were stimulated with BALB/c APC   HNT peptide; and
OT-II TCR Tg T cells were stimulated with C57BL/6 APC   OVA pep-
tide). All peptides were purchased from New England Peptide. Th1 effec-
tors were generated by culture with IL-2, IL-12, and anti–IL-4, and Th2 ef-
fectors were generated by culture with IL-2, IL-4, and anti-IFN  as
described previously (8).
Acutely stimulated CD4 effectors (Th1 and Th2) were generated in
vitro by adding peptide-pulsed APC at day 0, followed by the addition of
fresh nonpulsed APCs every 24 h. Repeatedly stimulated CD4 effectors
(Th1RS and Th2RS) were generated by adding peptide-pulsed APCs at
day 0, followed by addition of fresh peptide-pulsed APCs every 24 h.
Acutely stimulated polyclonal effectors were generated by culturing naive
polyclonal BALB/c ByJ CD4 T cells for 48 h on plate-bound anti-CD3 (10
 g/ml) with soluble anti-CD28 (5  g/ml), and then removing the T cells
without washing to uncoated flasks for the last 48 h of culture (8). Repeat-
edly stimulated polyclonal effectors were generated by culturing on the
plate-bound anti-CD3 for the entire 96 h of culture.
10   106 4-d effector T cells were transferred i.v. into AT BM mice
as previously described (9), and allowed to return to a resting state for 21 d.
25-d memory T cells were harvested from spleens and peripheral lymph
nodes, enumerated, and assayed by ELISA for cytokine production.
Analysis of cytokine production. T cells (5   105/ml) were restimu-
lated for 24 h with 10  g/ml plate-bound anti-CD3, unless indicated oth-
erwise, and culture supernatants were analyzed by ELISA (8). Alternatively,
T cells (5   105/ml) were restimulated for 24 h with T-depleted, spleen-
derived APC blasts (5   105/ml) that were pulsed with peptide Ag (10  g/
ml), followed by ELISA or ICCS as described previously (8).
Flow cytometry. Lymphocytes were stained with saturating concentra-
tions of fluorochrome-labeled mAbs as described previously (8). All surface-
staining reagents were purchased from BD Biosciences. PE-labeled anti-
V 3 (AND TCR Tg), anti-V 8.3 (HNT TCR Tg), anti-V 5 (OT-II
TCR Tg), allophycocyanin or peridium chlorophyll protein–labeled anti-
CD4 and peridium chlorophyll protein–labeled anti-Thy1.1 were used to
identify donor CD4 T cells in all FACS analysis. Flow cytometry was per-
formed using FACScalibur flow cytometers (BD Biosciences), and the data
were analyzed with FlowJo software (Tree Star, Inc.).
Restimulation of T cells with common  -chain–binding cytokines.
4-d effector T cells were washed extensively, labeled with CFSE, and cul-
tured at 2   105/ml with the indicated concentration of common  -chain
binding cytokines (Preprotech).
Virus infections. A/PR/8/34 (PR8) strain of influenza A virus was
grown in the allantoic fluid of 10-d-old embryonated chicken eggs, from an
aliquot that originally was obtained from D. Morgan (The Scripps Research
Institute, La Jolla, CA). Mice were inoculated intranasally during light iso-
flurane anesthesia with 50   103 PFU/ml (2LD50) of virus in 100  l PBS.
5   106, 2.5   106, or 0.5   106 4-d effectors that were generated in vitro
from Thy1.1 HNT TCR Tg CD4 T cells, or 200  l of PBS alone, were
transferred i.v. into infected mice. Donor and host T cells were isolated for
analysis 4 d following transfer from draining lymph nodes (parathymic and
mediastinal), spleens, and perfused lungs as previously described (3).
Analysis of B cell help. C57BL/6   CD4 KO mice were immunized
by i.p. injection of 200  g 4-hydroxy-3-nitrophenyl acetyl (Sigma-Aldrich)
conjugated OVA (NP-OVA) or PBS in 100  l alum (Sigma-Aldrich). 107,
106, or 105 4-d effectors that were generated in vitro from OT-II TCR Tg
CD4 T cells, or 200  l of PBS alone, were transferred i.v. into immunized
mice. Host B cells were isolated from spleens 16 d following transfer, and
serum was harvested from blood. The total number of host NP-specific,
germinal center phenotype (CD38lo/PNAhi) B cells were calculated by as-JEM VOL. 201, April 4, 2005 1111
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sessing the percentage of NP-APC /CD38-PElo/PNA-FITChi host B cells,
multiplied by the total number of live lymphocytes that were recovered
from the spleen. Serum samples were analyzed by ELISA for the presence of
NP-specific IgG1.
In vivo effector generation. 106 naive AND TCR Tg   GFP CD4 T
cells were mixed with 2   105 PCCF peptide-pulsed DCs and transferred
i.v. into intact B10.Br mice. Subsequently, 2   105 DCs without PCCF
peptide (acute stimulation) or 2   105 PCCF peptide-pulsed DCs (RS)
were transferred on days 1–4. Alternatively, 2   106 naive HNT TCR Tg
CD4 T cells were mixed with 2   106 HNT peptide-pulsed DCs and trans-
ferred i.v. into intact B10.Br mice. Subsequently, 2   106 DCs without
HNT peptide (acute stimulation) or 2   106 HNT peptide-pulsed DCs
(RS) were transferred on days 1–4. The numbers of naive CD4 T cells and
peptide pulsed DCs were titrated to ensure optimal CD4 effector responses
under conditions of acute stimulation. The in vivo generated effectors were
harvested 5 d following transfer.
This work was supported by National Institutes of Health grants (AI26887, AI4650, 
and HL3925 to S.L. Swain and AG21054 to L. Haynes) and by the Trudeau Institute.
The authors have no conflicting financial interests.
Submitted: 7 September 2004
Accepted: 1 February 2005
REFERENCES
1. Swain, S.L., L.M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A.D.
Weinberg, D.D. Duncan, S.M. Hedrick, R.W. Dutton, and G. Huston.
1991. Helper T-cell subsets: phenotype, function and the role of lym-
phokines in regulating their development. Immunol. Rev. 123:115–144.
2. Rogers, P.R., C. Dubey, and S.L. Swain. 2000. Qualitative changes
accompany memory T cell generation: faster, more effective responses
at lower doses of antigen. J. Immunol. 164:2338–2346.
3. Roman, E., E. Miller, A. Harmsen, J. Wiley, U.H. Von Andrian, G.
Huston, and S.L. Swain. 2002. CD4 effector T cell subsets in the re-
sponse to influenza: heterogeneity, migration, and function. J. Exp.
Med. 196:957–968.
4. Lanzavecchia, A., and F. Sallusto. 2002. Progressive differentiation
and selection of the fittest in the immune response. Nat. Rev. Immunol.
2:982–987.
5. Gett, A.V., F. Sallusto, A. Lanzavecchia, and J. Geginat. 2003. T cell
fitness determined by signal strength. Nat. Immunol. 4:355–360.
6. Bousso, P., and E. Robey. 2003. Dynamics of CD8  T cell priming
by dendritic cells in intact lymph nodes. Nat. Immunol. 4:579–585.
7. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of
antigenic stimulation determines the fate of naive and effector T cells.
Immunity. 8:89–95.
8. Jelley-Gibbs, D.M., N.M. Lepak, M. Yen, and S.L. Swain. 2000. Two
distinct stages in the transition from naive CD4 T cells to effectors,
early antigen-dependent and late cytokine-driven expansion and differ-
entiation. J. Immunol. 165:5017–5026.
9. Swain, S.L. 1994. Generation and in vivo persistence of polarized Th1
and Th2 memory cells. Immunity. 1:543–552.
10. Bird, J.J., D.R. Brown, A.C. Mullen, N.H. Moskowitz, M.A. Ma-
howald, J.R. Sider, T.F. Gajewski, C.R. Wang, and S.L. Reiner.
1998. Helper T cell differentiation is controlled by the cell cycle.
Immunity. 9:229–237.
11. Wherry, E.J., and R. Ahmed. 2004. Memory CD8 T-cell differentia-
tion during viral infection. J. Virol. 78:5535–5545.
12. Langenkamp, A., G. Casorati, C. Garavaglia, P. Dellabona, A. Lanza-
vecchia, and F. Sallusto. 2002. T cell priming by dendritic cells: thresh-
olds for proliferation, differentiation and death and intraclonal func-
tional diversification. Eur. J. Immunol. 32:2046–2054.
13. Wong, P., and E.G.P. Am. 2003. Feedback regulation of pathogen-
specific T cell priming. Immunity. 18:499–511.
14. van Stipdonk, M.J., E.E. Lemmens, and S.P. Schoenberger. 2001. Na-
ive CTLs require a single brief period of antigenic stimulation for
clonal expansion and differentiation. Nat. Immunol. 2:423–429.
15. Kemp, R.A., and F. Ronchese. 2001. Tumor-specific Tc1, but not Tc2,
cells deliver protective antitumor immunity. J. Immunol. 167:6497–6502.
16. Maloy, K.J., C. Burkhart, T.M. Junt, B. Odermatt, A. Oxenius, L. Piali,
R.M. Zinkernagel, and H. Hengartner. 2000. CD4( ) T cell subsets
during virus infection. Protective capacity depends on effector cytokine
secretion and on migratory capability. J. Exp. Med. 191:2159–2170.
17. De Mattia, F., S. Chomez, F. Van Laethem, V. Moulin, J. Urbain, M.
Moser, O. Leo, and F. Andris. 1999. Antigen-experienced T cells un-
dergo a transient phase of unresponsiveness following optimal stimula-
tion. J. Immunol. 163:5929–5936.
18. Lim, D.G., P. Hollsberg, and D.A. Hafler. 2002. Strength of prior
stimuli determines the magnitude of secondary responsiveness in CD8 
T cells. Cell. Immunol. 217:36–46.
19. Schwartz, R.H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305–334.
20. Miga, A.J., S.R. Masters, B.G. Durell, M. Gonzalez, M.K. Jenkins, C.
Maliszewski, H. Kikutani, W.F. Wade, and R.J. Noelle. 2001. Den-
dritic cell longevity and T cell persistence is controlled by CD154-
CD40 interactions. Eur. J. Immunol. 31:959–965.
21. Teh, H.S., and S.J. Teh. 1997. High concentrations of antigenic ligand
activate and do not tolerize naive CD4 T cells in the absence of CD28/
B7 costimulation. Cell. Immunol. 179:74–83.
22. Bradley, L.M., S.R. Watson, and S.L. Swain. 1994. Entry of naive
CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp.
Med. 180:2401–2406.
23. Hernandez-Caselles, T., M. Martinez-Esparza, A.I. Lazarovits, and
P. Aparicio. 1996. Specific regulation of VLA-4 and alpha 4 beta 7
integrin expression on human activated T lymphocytes. J. Immunol.
156:3668–3677.
24. Hirata, T., G. Merrill-Skoloff, M. Aab, J. Yang, B.C. Furie, and B. Fu-
rie. 2000. P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological
ligand for E-selectin in mediating T helper 1 lymphocyte migration. J.
Exp. Med. 192:1669–1676.
25. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999.
Two subsets of memory T lymphocytes with distinct homing poten-
tials and effector functions. Nature. 401:708–712.
26. Langenkamp, A., K. Nagata, K. Murphy, L. Wu, A. Lanzavecchia, and
F. Sallusto. 2003. Kinetics and expression patterns of chemokine recep-
tors in human CD4  T lymphocytes primed by myeloid or plasmacy-
toid dendritic cells. Eur. J. Immunol. 33:474–482.
27. Bot, A., S. Bot, and C.A. Bona. 1998. Protective role of gamma inter-
feron during the recall response to influenza virus. J. Virol. 72:6637–6645.
28. Brown, D.M., E. Roman, and S.L. Swain. 2004. CD4 T cell responses
to influenza infection. Semin. Immunol. 16:171–177.
29. Graham, M.B., V.L. Braciale, and T.J. Braciale. 1994. Influenza virus-
specific CD4  T helper type 2 T lymphocytes do not promote recov-
ery from experimental virus infection. J. Exp. Med. 180:1273–1282.
30. Foy, T.M., A. Aruffo, J. Bajorath, J.E. Buhlmann, and R.J. Noelle.
1996. Immune regulation by CD40 and its ligand GP39. Annu. Rev.
Immunol. 14:591–617.
31. Eaton, S.M., E.M. Burns, K. Kusser, T.D. Randall, and L. Haynes.
2004. Age-related defects in CD4 T cell cognate helper function lead
to reductions in humoral responses. J. Exp. Med. 200:1613–1622.
32. Odermatt, B., M. Eppler, T.P. Leist, H. Hengartner, and R.M. Zink-
ernagel. 1991. Virus-triggered acquired immunodeficiency by cyto-
toxic T-cell-dependent destruction of antigen-presenting cells and
lymph follicle structure. Proc. Natl. Acad. Sci. USA. 88:8252–8256.
33. Loyer, V., P. Fontaine, S. Pion, F. Hetu, D.C. Roy, and C. Perreault.
1999. The in vivo fate of APCs displaying minor H antigen and/or
MHC differences is regulated by CTLs specific for immunodominant
class I-associated epitopes. J. Immunol. 163:6462–6467.
34. Hermans, I.F., D.S. Ritchie, J. Yang, J.M. Roberts, and F. Ronchese.
2000. CD8  T cell-dependent elimination of dendritic cells in vivo lim-
its the induction of antitumor immunity. J. Immunol. 164:3095–3101.
35. Li, J., G. Huston, and S.L. Swain. 2003. IL-7 promotes the transition of
CD4 effectors to persistent memory cells. J. Exp. Med. 198:1807–1815.
36. Ku, C.C., B. Kotzin, J. Kappler, and P. Marrack. 1997. CD8  T-cell
clones in old mice. Immunol. Rev. 160:139–144.REPEATED STIMULATION LIMITS CD4 T CELL FUNCTION | Jelley-Gibbs et al. 1112
37. Thompson, S.D., M. Larche, A.R. Manzo, and J.L. Hurwitz. 1992.
Diversity of T-cell receptor alpha gene transcripts in the newborn and
adult periphery. Immunogenetics. 36:95–103.
38. Mackall, C.L., C.V. Bare, L.A. Granger, S.O. Sharrow, J.A. Titus,
and R.E. Gress. 1996. Thymic-independent T cell regeneration oc-
curs via antigen-driven expansion of peripheral T cells resulting in a
repertoire that is limited in diversity and prone to skewing. J. Immunol.
156:4609–4616.
39. Goronzy, J.J., and C.M. Weyand. 2003. Aging, autoimmunity and ar-
thritis: T-cell senescence and contraction of T-cell repertoire diversity—
catalysts of autoimmunity and chronic inflammation. Arthritis Res.
Ther. 5:225–234.
40. Grabstein, K.H., C.R. Maliszewski, K. Shanebeck, T.A. Sato, M.K.
Spriggs, W.C. Fanslow, and R.J. Armitage. 1993. The regulation of T
cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
J. Immunol. 150:3141–3147.
41. Erickson, L.D., B.G. Durell, L.A. Vogel, B.P. O’Connor, M. Cas-
calho, T. Yasui, H. Kikutani, and R.J. Noelle. 2002. Short-circuiting
long-lived humoral immunity by the heightened engagement of
CD40. J. Clin. Invest. 109:613–620.
42. Gregers, T.F., B. Fleckenstein, F. Vartdal, P. Roepstorff, O. Bakke,
and I. Sandlie. 2003. MHC class II loading of high or low affinity pep-
tides directed by Ii/peptide fusion constructs: implications for T cell
activation. Int. Immunol. 15:1291–1299.
43. Borovsky, Z., G. Mishan-Eisenberg, E. Yaniv, and J. Rachmilewitz.
2002. Serial triggering of T cell receptors results in incremental accu-
mulation of signaling intermediates. J. Biol. Chem. 277:21529–21536.
44. Ben-Sasson, S.Z., R. Gerstel, J. Hu-Li, and W.E. Paul. 2001. Cell di-
vision is not a “clock” measuring acquisition of competence to pro-
duce IFN-gamma or IL-4. J. Immunol. 166:112–120.
45. Weng, X., E. Priceputu, P. Chrobak, J. Poudrier, D.G. Kay, Z.
Hanna, T.W. Mak, and P. Jolicoeur. 2004. CD4  T cells from
CD4C/HIVNef transgenic mice show enhanced activation in vivo
with impaired proliferation in vitro but are dispensable for the devel-
opment of a severe AIDS-like organ disease. J. Virol. 78:5244–5257.
46. Winslow, G.M., A.D. Roberts, M.A. Blackman, and D.L. Woodland.
2003. Persistence and turnover of antigen-specific CD4 T cells during
chronic tuberculosis infection in the mouse. J. Immunol. 170:2046–2052.
47. Schnittman, S.M., H.C. Lane, J. Greenhouse, J.S. Justement, M.
Baseler, and A.S. Fauci. 1990. Preferential infection of CD4  memory
T cells by human immunodeficiency virus type 1: evidence for a role
in the selective T-cell functional defects observed in infected individu-
als. Proc. Natl. Acad. Sci. USA. 87:6058–6062.
48. Callan, M.F. 2003. The evolution of antigen-specific CD8  T cell re-
sponses after natural primary infection of humans with Epstein-Barr virus.
Viral Immunol. 16:3–16.
49. Scott, P., D. Artis, J. Uzonna, and C. Zaph. 2004. The development of
effector and memory T cells in cutaneous leishmaniasis: the implica-
tions for vaccine development. Immunol. Rev. 201:318–338.
50. Dunachie, S.J., and A.V. Hill. 2003. Prime-boost strategies for malaria
vaccine development. J. Exp. Biol. 206:3771–3779.